'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

AstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was ever planned. This comes after reports of preliminary talks between the two major drugmakers. AstraZeneca shares experienced a significant decline following the initial deal speculation. Both companies declined to comment on the reported discussions.